BUY Supriya Lifescience Limited — Dharmesh Shah, ICICI Securities

byDharmesh Shah, ICICI SecuritiesHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via ET Now (Live)

Entry₹979Inferred
Target₹1,011
Stop loss₹905-7.56% risk
CMP₹961.7512h ago
Active-1.76%+5.12%upside left 13d left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Sept, 4:18 am IST
3 supporting0 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·24 Sept · today

Supriya Lifescience FY26 net profit rises 11% to ₹2,091.2 million

NewsGoogle News·20 Sept · 4d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·6 Jul · 3mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.